GlassScriptPhysician profile
Nadia Fida
NPI 1609043637
$6,076.47
in general payments reported to CMS, 2019-2025
31 companies · $441 in 2025
The $441 reported for 2025 was less than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
See the full distribution for Advanced Heart Failure and Transplant Cardiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,242 · 2020: $356 · 2021: $557 · 2022: $775 · 2023: $1,978 · 2024: $727 · 2025: $441.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,634 · Travel and Lodging: $513.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,633.55 |
| Travel and Lodging | $512.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,620.24 | 2019-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit, Mitraclip |
| Abiomed | $1,146.20 | 2019-2023 | Impella |
| Actelion Pharmaceuticals US, INC. | $305.20 | 2019-2025 | Uptravi, Opsumit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $279.78 | 2019-2024 | Lifevest |
| Boston Scientific Corporation | $227.66 | 2019-2024 | Watchman Access System, Lux-Dx Insertable Cardiac Monitor |
| Impulse Dynamics (USA) INC. | $191.89 | 2023-2024 | Optimizer, Optimizer |
| Amgen INC. | $165.52 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $147.63 | 2019-2024 | |
| Bridgebio Pharma, INC. | $124.35 | 2025 | Attruby |
| Baxter Healthcare | $106.24 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Novartis Pharmaceuticals Corporation | $101.57 | 2019-2024 | |
| Medtronic Vascular, INC. | $94.31 | 2019-2020 | |
| Medtronic, INC. | $75.71 | 2025 | Azure Xt Dr Mri Surescan |
| Tactile Systems Technology INC | $71.99 | 2022-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Janssen Pharmaceuticals, INC | $65.91 | 2019-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $37.78 | 2022 | |
| Alnylam Pharmaceuticals INC. | $35.75 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $31.43 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $29.96 | 2024-2025 | Camzyos |
| Heartflow, INC. | $25.69 | 2019 | |
| Edwards Lifesciences Corporation | $22.72 | 2022 | |
| Cvrx, INC. | $22.24 | 2022 | |
| Astellas Pharma US INC | $22.06 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.81 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.55 | 2023 | Jardiance |
| Elutia, INC. | $18.35 | 2022 | |
| Abbvie INC. | $15.43 | 2024 | |
| Haemonetics Corporation | $14.42 | 2019 | |
| Ge Healthcare | $13.03 | 2019 | |
| Braemar Manufacturing, LLC | $11.05 | 2019 | |
| Bardy Diagnostics, INC. | $10.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nadia Fida listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.